Hepatitis C-Free Europe is Possible by 2030

Home » Hepatitis C-Free Europe is Possible by 2030

Hepatitis C-Free Europe is Possible by 2030

Female Scientific Research Team With Clear Solution In LaboratorEurope’s leading experts, medical specialists and patient advocacy groups on hepatitis announced their intention to work towards the elimination of the hepatitis C virus (HCV) in Europe by 2030.The ‘Hepatitis C Elimination Manifesto’ was presented at the first EU HCV Policy Summit, organized by the Hepatitis B and C Public Policy Association, and supported by the main European patient and clinician groups. Signatories of the ‘Hepatitis C Elimination Manifesto’ pledge to

  • make hepatitis C and its elimination in Europe an explicit public health priority to be pursued at all levels
  • ensure that patients, civil society groups and other relevant stakeholders are directly involved in developing and implementing hepatitis C elimination strategies
  • pay particular attention to the links between hepatitis C and social marginalization
  • introduce a European Hepatitis Awareness Week.

Vytenis Andriukaitis, Commissioner for Health and Food Safety, delivered a keynote speech at the event, commenting: “Hepatitis C has in the past been referred to as a ‘silent’ epidemic within the European Union. It is high time that we brought this silent epidemic out of the shadows and into the light, so I welcome initiatives such as this Summit and the Elimination Manifesto to create momentum for action, for raising awareness and for stimulating discussion.”

After 25 years of research, scientists have delivered the means to effectively cure hepatitis C, paving the way for elimination in Europe within the next decade. “What would have taken a hundred years for us to achieve, is now at hand! This is a unique opportunity, but political action is needed to make this happen,” stated Prof. Angelos Hatzakis, Co-Chair of the Hepatitis B and C Public Policy Association. “Our ‘Elimination Manifesto’ is a rallying platform for policy makers and advocates. If we act now, Europe will be hepatitis C free by 2030,” continued Prof. Hatzakis.

The specific challenges of hepatitis C require holistic, people-centred, health system-wide approaches to disease awareness, prevention and integrated care, with all stakeholders combining their diverse skills and resources in a unified response.

“Succeeding against hepatitis C in Europe is even more important given the current international crises and refugee flows towards our countries,” explained Cristian-Silviu Busoi, Member of the European Parliament and Co-chair of the Parliament’s Friends of the Liver group. Busoi continued: “Elimination strategies need to take into consideration the links between hepatitis C and marginalized groups, such as recent migrants, people who inject drugs and others.”

“The Manifesto sets out our vision and commitment to eliminate hepatitis C in Europe,” declared Prof. Michael P. Manns, Co-Chair of the Hepatitis B and C Public Policy Association: “Concrete actions at all levels must follow to achieve our goal.” The Manifesto will be presented to national and local governments as well as to the European institutions to encourage action.